NPS Pharmaceuticals NPSP today announced that NASDAQ has halted trading of
the company's common stock.
The U.S. Food and Drug Administration's (FDA) Gastrointestinal Drugs
Advisory Committee is meeting today to review Gattex® (teduglutide), a
novel, recombinant analog of human glucagon-like peptide 2 (a protein
involved in the rehabilitation of the intestinal lining) being developed
for the treatment of adults with short bowel syndrome.
The Advisory Committee meeting is scheduled for 8:00 a.m. ET. The
briefing materials can be found on the FDA website at http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm291609.htm.
The Prescription Drug User Fee Act date for completion of
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in